Liraglutide Injection
Lupin is recalling Liraglutide Injection (NDC 70748-346-02 and 70748-346-03) due to white thread-like particulate matter in the cartridge.
Inspect your medication for any visible particles. If you identify a white thread-like structure, do not use the product and contact your healthcare provider or pharmacist for a replacement.
Why it was recalled
Presence of particulate matter: a white thread-like structure in the cartridge
How to identify it
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Where it was sold
Distributed in US.
Official source
Editorial summary by Recall Canary · last updated 2026-05-20 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification